Clinical Trials Directory

Trials / Unknown

UnknownNCT05592470

commd7 Gene Expression in ALL

The Copper Metabolism MURR1 Domain 7 (COMMD7) Gene Expression in Acute Lymphoblastic Leukemia

Status
Unknown
Phase
Study type
Observational
Enrollment
102 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
Healthy volunteers

Summary

* study the expression pattern of COMMD7 gene in acute lymphoblastic leukemia. * investigate correlation between the expression level of COMMD7 gene with other diagnostic parameters and prognosis in ALL .

Detailed description

Acute lymphoblastic leukemia (ALL) is a neoplastic disorder of lymphoid progenitor cells characterized by diverse cytogenetic and molecular abnormalities with peaks of prevalence for 2-5-year-old patients and those older than 50. Treatment strategies using risk-adapted chemotherapy cure more than 80% of childhood cases, but around 20 to 30% relapse developing serious complications including death.( 1) In the past decade, the available treatments for patients with acute lymphoblastic leukemia (ALL) have rapidly expanded, in parallel with an increased understanding of the genomic features that impact the disease biology and clinical outcomes.(2) The copper metabolism MURR1 domain (COMMD) protein family involved in tumor development and progression in several types of human cancer, but little is known about the function of COMMD proteins in hematological malignancy. (3) COMMD7, a member of the COMMD, which is located on chromosome 20q11.21, has been reported associated with tumor progression in human solid cancers \[4\]. COMMD7 is overexpressed in pancreatic ductal adenocarcinoma (PDAC) cells, associated with poor prognosis. \[5\]. Another study revealed that COMMD7-overexpressed hepatocellular carcinoma (HCC) cells promoted the proliferation of naïve HCC cells (6) A recent study was found that high expression of COMMD7 is a potential biomarker for adverse outcomes and poor prognosis in AML. (7) . However, to date, the expression of COMMD7 in acute lymphoblastic leukemia and its prognostic value remain unclear.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTReverse transcription-quantitative polymerase chain reaction (RT-qPCR).Reverse transcription-quantitative polymerase chain reaction on bone marrow aspirates to detect The expression pattern of COMMD7 gene in acute lymphoblastic leukemia

Timeline

Start date
2022-11-01
Primary completion
2024-04-01
Completion
2024-11-01
First posted
2022-10-24
Last updated
2022-10-24

Source: ClinicalTrials.gov record NCT05592470. Inclusion in this directory is not an endorsement.